» Articles » PMID: 27144627

Bowel Disorders

Overview
Specialty Gastroenterology
Date 2016 May 5
PMID 27144627
Citations 1021
Authors
Affiliations
Soon will be listed here.
Abstract

Functional bowel disorders are highly prevalent disorders found worldwide. These disorders have the potential to affect all members of society, regardless of age, gender, race, creed, color or socioeconomic status. Improving our understanding of functional bowel disorders (FBD) is critical as they impose a negative economic impact to the global health care system in addition to reducing quality of life. Research in the basic and clinical sciences during the past decade has produced new information on the epidemiology, etiology, pathophysiology, diagnosis and treatment of FBDs. These important findings created a need to revise the Rome III criteria for FBDs, last published in 2006. This manuscript classifies the FBDs into five distinct categories: irritable bowel syndrome (IBS); functional constipation (FC); functional diarrhea (FDr); functional abdominal bloating/distention (FAB/D); and unspecified FBD (U-FBD). Also included in this article is a new sixth category, opioid induced constipation (OIC) which is distinct from the functional bowel disorders (FBDs). Each disorder will first be defined, followed by sections on epidemiology, rationale for changes from prior criteria, clinical evaluation, physiologic features, psychosocial features and treatment. It is the hope of this committee that this new information will assist both clinicians and researchers in the decade to come.

Citing Articles

Complex Probiotics Ameliorate Fecal Microbiota Transplantation-Induced IBS in Mice via Gut Microbiota and Metabolite Modulation.

Gao Y, Borjihan Q, Zhang W, Li L, Wang D, Bai L Nutrients. 2025; 17(5).

PMID: 40077671 PMC: 11902000. DOI: 10.3390/nu17050801.


Naloxegol for the Treatment of Opioid-Induced Constipation in Patients with Cancer Pain: A Pooled Analysis of Real-World Data.

Sabate J, Beato-Zambrano C, Cobo M, Lemaire A, Montesarchio V, Serna-Montros J Cancers (Basel). 2025; 17(5).

PMID: 40075711 PMC: 11898930. DOI: 10.3390/cancers17050865.


Etiologies of exocrine pancreatic insufficiency.

Tang C, Zhou J, Song Y, Liu S Gastroenterol Rep (Oxf). 2025; 13:goaf019.

PMID: 40066317 PMC: 11893156. DOI: 10.1093/gastro/goaf019.


Irritable bowel syndrome remains a complex disorder of gut-brain interaction: Too many actors on stage.

Pellegrino R, Gravina A World J Gastroenterol. 2025; 31(8):101357.

PMID: 40062329 PMC: 11886521. DOI: 10.3748/wjg.v31.i8.101357.


Quality of life, functional impairment and healthcare experiences of patients with irritable bowel syndrome in Norway: an online survey.

El-Salhy M, Johansson M, Klevstul M, Hatlebakk J BMC Gastroenterol. 2025; 25(1):143.

PMID: 40050743 PMC: 11883911. DOI: 10.1186/s12876-025-03685-6.